Elizabeth and the Monster (eventually) do it in Young Frankenstein
Seven additional studies evaluated the efficacy of CHANTIX in patients with cardiovascular disease, in patients with chronic obstructive pulmonary disease [see Clinical Studies (14.7)], in patients instructed to select their quit date within days 8 and 35 of treatment [see Clinical Studies (14.4)], patients with major depressive disorder [see Clinical Studies (14.9)], patients who had made a previous attempt to quit smoking with CHANTIX, and either did not succeed in quitting or relapsed after treatment [see Clinical Studies (14.6)], in patients without or with a history of psychiatric disorder enrolled in a postmarketing neuropsychiatric safety outcome trial [see Warnings and Precautions (5.1), Clinical Studies (14.10)], and in patients who were not able or willing to quit abruptly and were instructed to quit gradually [see Clinical studies (14.5)]
The troubled 28-year-old was bundled in a hooded off-white coat over a colourful blouse, brown leggings, and grey suede boots
Four of the worlds five largest TTCs British American Tobacco (BAT), Philip Morris International (PMI), Japan Tobacco International (JTI), and Imperial Brands (IB, formerly Imperial Tobacco Group) control the cigarette markets in most countries in ASEAN
In January, Malcolm Ahlo, our ASPiRE CAB member in Las Vegas, was offered the chance to apply for a grant [...] Secret pacts between tobacco companies and retailers are a bad bargain for public health Tobacco companies handsomely incentivize retailers around the world to follow harsh requirements related to selling and marketing tobacco products through contracts that fly under the radar of both consumers and policymakers
